This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ryffel, B. Articles by Mihatsch, M. J. Search for Related Content PubMed PubMed Citation Articles by Ryffel, B. Articles by Mihatsch, M. J.

American Journal of Pathology, Vol 144, 927-937, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice

B Ryffel, BD Car, H Gunn, D Roman, P Hiestand and MJ Mihatsch
Institute of Toxicology, Faculty of Medicine, University of Zurich, Switzerland.

The ability of interleukin-6 (IL-6) to modulate immune parameters and mesangial cell function suggests a role for this cytokine in the development of autoimmune glomerulonephritis. This hypothesis was tested in 6-month-old female (NZB x NZW)F1 mice that were administered recombinant human IL-6 (rhIL-6) (50 and 250 micrograms/kg s.c.) for 12 weeks, resulting in an accelerated and severe form of membranoproliferative glomerulonephritis associated with marked upregulation of mesangial major histocompatibility complex class II antigen and glomerular ICAM-1 expression. To distinguish direct effects of rhIL-6 on the renal mesangium from those mediated through the immune system, (NZB x NZW)F1 mice were immunosuppressed with cyclosporin. Immunosuppression by cyclosporin inhibited the development of glomerulonephritis, decreased class II antigen expression, and abrogated IL-6-mediated effects. Administration of neutralizing anti-IL- 6 antibody had no effect on the spontaneous development of glomerulonephritis in (NZB x NZW)F1 mice. This finding, together with undetectable IL-6 serum levels, makes a pathogenetic role of endogenously produced IL-6 in this disease model unlikely. In contrast to (NZB x NZW)F1 mice, parental NZW or BALB/c mice given high doses of rhIL-6 (500 micrograms/kg) or recombinant murine IL-6 (100 micrograms/kg) daily for 4 weeks failed to develop morphological or biochemical evidence of glomerulonephritis. Induction of acute phase proteins, anemia, thrombocytosis, and induction of renal class II antigen confirmed the biological activity of IL-6 in these mice. In conclusion, while non-nephritogenic in normal mice, IL-6 accelerates the development of the genetically determined glomerulonephritis of (NZB x NZW)F1 mice through effects mediated by a modulated immune system. Since neutralizing IL-6 antibody treatment did not prevent the development of glomerulonephritis, it is unlikely that increased IL-6 production plays a role in the pathogenesis of lupus nephritis.

This article has been cited by other articles:

				M. Yamauchi, M. Hashimoto, K. Ichiyama, R. Yoshida, T. Hanada, T. Muta, S. Komune, T. Kobayashi, and A. Yoshimura Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-{kappa}B activation in dendritic cells Int. Immunol., August 16, 2007; (2007) dxm054v1. [Abstract] [Full Text] [PDF]

				M. R. Gilbert, D. G. Carnathan, P. C. Cogswell, L. Lin, A. S. Baldwin Jr, and B. J. Vilen Dendritic Cells from Lupus-Prone Mice Are Defective in Repressing Immunoglobulin Secretion J. Immunol., April 15, 2007; 178(8): 4803 - 4810. [Abstract] [Full Text] [PDF]

				B. D. Palma, A. Gabriel Jr., F. A. B. Colugnati, and S. Tufik Effects of sleep deprivation on the development of autoimmune disease in an experimental model of systemic lupus erythematosus Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1527 - R1532. [Abstract] [Full Text] [PDF]

				M. J. Ryan, G. R. McLemore Jr, and S. T. Hendrix Insulin Resistance and Obesity in a Mouse Model of Systemic Lupus Erythematosus Hypertension, November 1, 2006; 48(5): 988 - 993. [Abstract] [Full Text] [PDF]

				S. Yung, R. C.W. Tsang, Y. Sun, J. K.H. Leung, and T. M. Chan Effect of Human Anti-DNA Antibodies on Proximal Renal Tubular Epithelial Cell Cytokine Expression: Implications on Tubulointerstitial Inflammation in Lupus Nephritis J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3281 - 3294. [Abstract] [Full Text] [PDF]

				J S Smolen, G Steiner, and M Aringer Anti-cytokine therapy in systemic lupus erythematosus Lupus, March 1, 2005; 14(3): 189 - 191. [Abstract] [PDF]

				M Aringer and J S Smolen Cytokine expression in lupus kidneys Lupus, January 1, 2005; 14(1): 13 - 18. [Abstract] [PDF]

				E Tackey, P E Lipsky, and G G Illei Rationale for interleukin-6 blockade in systemic lupus erythematosus Lupus, May 1, 2004; 13(5): 339 - 343. [Abstract] [PDF]

				M Aringer and J S Smolen Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention Lupus, May 1, 2004; 13(5): 344 - 347. [Abstract] [PDF]

				C. Viedt and S. R. Orth Monocyte chemoattractant protein-1 (MCP-1) in the kidney: does it more than simply attract monocytes? Nephrol. Dial. Transplant., December 1, 2002; 17(12): 2043 - 2047. [Full Text] [PDF]

				C. Viedt, R. Dechend, J. Fei, G. M. Hansch, J. Kreuzer, and S. R. Orth MCP-1 Induces Inflammatory Activation of Human Tubular Epithelial Cells: Involvement of the Transcription Factors, Nuclear Factor-{kappa}B and Activating Protein-1 J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1534 - 1547. [Abstract] [Full Text] [PDF]

				M. Yanagita, H. Arai, K. Ishii, T. Nakano, K. Ohashi, K. Mizuno, B. Varnum, A. Fukatsu, T. Doi, and T. Kita Gas6 Regulates Mesangial Cell Proliferation through Axl in Experimental Glomerulonephritis Am. J. Pathol., April 1, 2001; 158(4): 1423 - 1432. [Abstract] [Full Text] [PDF]

				H Sato, Y Akai, M Iwano, N Kurumatani, H Kurioka, A Kubo, T Yamaguchi, T Fujimoto, and K Dohi Association of an insertion polymorphism of angiotensinconverting enzyme gene with the activity of systemic lupus erythematosus Lupus, October 1, 1998; 7(8): 530 - 534. [Abstract] [PDF]

				C. Haas, B. Ryffel, and M. Le Hir IFN-{gamma} Receptor Deletion Prevents Autoantibody Production and Glomerulonephritis in Lupus-Prone (NZB NZW)F1 Mice J. Immunol., April 15, 1998; 160(8): 3713 - 3718. [Abstract] [Full Text] [PDF]

				R Herrera-Esparza, O Barbosa-Cisneros, R Villalobos-Hurtado, and E Avalos-Diaz Renal expression of IL-6 and TNF{alpha} genes in lupus nephritis Lupus, March 1, 1998; 7(3): 154 - 158. [Abstract] [PDF]